By continuing to use the site you agree to our Privacy & Cookies policy

New immunotherapy approach targets HER2-positive breast cancer

A new technique aimed at harnessing the body’s immune system to attack one of the deadliest forms of breast cancer is being developed by British scientists.

Get unlimited access

As a subscriber you will benefit from:

  • Full online and mobile access to news and opinion stories
  • Customised email alerts straight to your inbox (over 30 alerts available)
  • 4,500 practice articles in our archive 
  • Over £500 worth of CPD learning units 
or

newsletterpromo